Molecular cloning of mouse thioredoxin reductases

Gene

Volumn 242, Issue 1-2, 2000, Pages 321-330

  Kawai, Hidehiko ^a   Ota, Takahide ^b   Suzuki, Fumio ^a   Tatsuka, Masaaki ^a  

^a Res Inst Nucl Med Biol   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Mapping; Mitochondria; Redox; Selenocysteine; Selenoprotein

Indexed keywords

COMPLEMENTARY DNA; HYBRID PROTEIN; SELENOCYSTEINE; SELENOPROTEIN; THIOREDOXIN REDUCTASE;

ANIMAL CELL; ARTICLE; CHROMOSOMAL LOCALIZATION; DNA LIBRARY; GENE LOCATION; GENE MAPPING; GENE TRANSLOCATION; GENETIC TRANSCRIPTION; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; THYMOCYTE;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; CLONING, MOLECULAR; DNA, COMPLEMENTARY; ISOENZYMES; MICE; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; RNA, MESSENGER; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY, AMINO ACID; THIOREDOXIN REDUCTASE (NADPH); TISSUE DISTRIBUTION;

ANIMALIA; RODENTIA;

EID: 0033969003     PISSN: 03781119     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1119(99)00498-9     Document Type: Article

References (31)

1. Bannister A.J., Cook A., Kouzarides T. In vitro DNA binding activity of Fos/Jun and BZLF1 but not C/EBP is affected by redox changes. Oncogene. 6:1991;1243-1250.
2. Chae H.Z., Robison K., Poole L.B., Church G., Storz G., Rhee S.G. Cloning and sequencing of thiol-specific antioxidant from mammalian brain: alkyl hydroperoxide reductase and thiol-specific antioxidant define a large family of antioxidant enzymes. Proc. Natl. Acad. Sci. USA. 91:1994;7017-7021.
3. Cromlish J.A., Roeder R.G. Human transcription factor IIIC (TFIIIC). Purification, polypeptide structure, and the involvement of thiol groups in specific DNA binding. J. Biol. Chem. 264:1989;18 100-18 109.
4. Demczuk S., Aurias A. DiGeorge syndrome and related syndromes associated with 22q11.2 deletions. Ann. Genet. 38:1995;59-76.
5. Gallegos A., Gasdaska J.R., Taylor C.W., Paine-Murrieta G.D., Goodman D., Gasdaska P.Y., Berggren M., Briehl M.M., Powis G. Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells. Cancer Res. 56:1995;5765-5770.
6. Gasdaska P.Y., Gasdaska J.R., Cochran S., Powis G. Cloning and sequencing of a human thioredoxin reductase. FEBS Lett. 373:1995;5-9.
7. Gasdaska P.Y., Berggren M.M., Berry M.J., Powis G. Cloning, sequencing and functional expression of a novel human thioredoxin reductase. FEBS Lett. 442:1999;105-111.
8. Gladyshev V.N., Jeang K.T., Stadtman T.C. Selenocysteine, identified as the penultimate C-terminal residue in human T-cell thioredoxin reductase, corresponds to TGA in the human placental gene. Proc. Natl. Acad. Sci. USA. 93:1996;6146-6151.
9. Gogos J.A., Morgan M., Luine V., Santha M., Ogawa S., Pfaff D., Karayiogou M. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior. Proc. Natl. Acad. Sci. USA. 95:1998;9991-9996.
10. Holmgren A. Thioredoxin. Annu. Rev. Biochem. 54:1985;237-271.
11. Katayama H., Ota T., Morita K., Terada Y., Suzuki F., Katoh O., Tatsuka M. Human AIM-1: cDNA cloning and reduced expression during endomitosis in megakaryocyte-lineage cells. Gene. 224:1998;1-7.
12. Lee S.R., Kwon K.S., Kim S.R., Rhee S.G. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J. Biol. Chem. 273:1998;15 366-15 372.
13. Lee S.R., Kim J.R., Kwon K.S., Yoon H.W., Levine R.L., Ginsburg A., Rhee S.G. Molecular cloning and characterization of a mitochondrial selenocysteine-containing thioredoxin reductase from rat liver. J. Biol. Chem. 274:1999;4722-4734.
14. Li X.Y., Mattei M.G., Zaleska-Rutczynska Z., Hooft van Huijsduijnen R., Figueroa F., Nadeau J., Benoist C., Mathis D. One subunit of the transcription factor NF-Y maps close to the major histocompatibility complex in murine and human chromosomes. Genomics. 11:1991;630-634.
15. Low S.C., Berry M.J. Knowing when not to stop: selenocysteine incorporation in eukaryotes. Trends Biochem. Sci. 21:1996;203-208.
16. Lund J., Roe B., Chen F., Budarf M., Galili N., Riblet R., Miller R.D., Emanuel B.S., Reeves R.H. Sequence-ready physical map of the mouse chromosome 16 region with conserved synteny to the human velocardiofacial syndrome region on 22q11.2. Mamm. Genome. 10:1999;438-443.
17. Lundstrom J., Holmgren A. Protein disulfide-isomerase is a substrate for thioredoxin reductase and has thioredoxin-like activity. J. Biol. Chem. 265:1990;9114-9120.
18. Luthman M., Holmgren A. Rat liver thioredoxin and thioredoxin reductase: purification and characterization. Biochemistry. 21:1982;6628-6633.
19. Matthews J.R., Wakasugi N., Virelizier J.L., Yodoi J., Hay R.T. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res. 20:1992;3821-3830.
20. McCarthy L.C., Terrett J., Davis M.E., Knights C.J., Smith A.L., Critcher R., Schmitt K., Hudson J., Spurr N.K., Goodfellow P.N. A first-generation whole genome-radiation hybrid map spanning the mouse genome. Genome Res. 7:1997;1153-1161.
21. Miranda-Vizuete A., Damdimopoulos A.E., Pedrajas J.R., Gustafsson J.A., Spyrou G. Human mitochondrial thioredoxin reductase cDNA cloning, expression and genomic organization. Eur. J. Biochem. 261:1999;405-412.
22. Neupert W. Transport of proteins across mitochondrial membranes. Clin. Investig. 72:1994;251-261.
23. Rauch A., Hofbeck M., Bahring S., Leipold G., Trautmann U., Singer H., Pfeiffer R.A. Monozygotic twins concordant for Cayler syndrome. Am. J. Med. Genet. 75:1998;113-117.
24. Schallreuter K.U., Wood J.M. The role of thioredoxin reductase in the reduction of free radicals at the surface of the epidermis. Biochem. Biophys. Res. Commun. 136:1986;630-637.
25. Spyrou G., Enmark E., Miranda-Vizuete A., Gustafsson J.-A. Cloning and expression of a novel mammalian thioredoxin. J. Biol. Chem. 272:1997;4984-4990.
26. Stadtman T.C. Selenocysteine. Annu. Rev. Biochem. 65:1996;83-100.
27. Tamura T., Stadtman T.C. A new selenoprotein from human lung adenocarcinoma cells: purification, properties, and thioredoxin reductase activity. Proc. Natl. Acad. Sci. USA. 93:1996;1006-1011.
28. Thelander L., Reichard P. Reduction of ribonucleotides. Annu. Rev. Biochem. 48:1979;133-158.
29. Walter A.E., Turner D.H., Kim J., Lyttle M.H., Muller P., Matthews D.H., Zuker M. Coaxial stacking of helixes enhances binding of oligoribonucleotides and improves predictions of RNA folding. Proc. Natl. Acad. Sci. USA. 91:1994;9218-9222.
30. Xanthoudakis S., Miao G., Wang F., Pan Y.C., Curran T. Redox activation of Fos-Jun DNA binding activity is mediated by a DNA repair enzyme. EMBO J. 11:1992;3323-3335.
31. Zhong L., Arn-er E.S., Ljung J., Aslund F., Holmgren A. Rat and calf thioredoxin reductase are homologous to glutathione reductase with a carboxyl-terminal elongation containing a conserved catalytically active penultimate selenocysteine residue. J. Biol. Chem. 273:1998;8581-8591.